• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全血基因表达谱与系统性红斑狼疮疾病活动度的关联

Association of a gene expression profile from whole blood with disease activity in systemic lupus erythaematosus.

作者信息

Nikpour M, Dempsey A A, Urowitz M B, Gladman D D, Barnes D A

机构信息

University of Toronto Lupus Clinic and Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada.

出版信息

Ann Rheum Dis. 2008 Aug;67(8):1069-75. doi: 10.1136/ard.2007.074765. Epub 2007 Dec 6.

DOI:10.1136/ard.2007.074765
PMID:18063674
Abstract

OBJECTIVE

To determine whether peripheral blood gene expression of patients with systemic lupus erythaematosus (SLE) correlates with disease activity measured using the SLE Disease Activity Index 2000 (SLEDAI-2K).

METHODS

RNA was isolated from peripheral blood of 269 patients with SLE and profiled on a custom microarray. Hierarchical clustering and a heat map were used to categorise samples into major clusters based on gene expression pattern. Correlates, including demographic and disease-related characteristics such as SLEDAI-2K score, of the major sample clusters were compared using multivariate regression models.

RESULTS

A set of 31 interferon (IFN)-regulated genes were seen to be driving the separations of samples into two clusters, one characterised by a relatively high IFN-regulated gene signature (n = 150) and the other by a relatively low IFN-regulated gene signature (n = 119). Disease activity measured using the SLEDAI-2K was significantly correlated with the high IFN gene signature. In multivariate regression analysis the immunological component of the SLEDAI-2K was a significant correlate of the high IFN gene signature as was presence of antibodies to U1RNP. There were no discernable correlates of the 156 non-IFN regulated genes profiled on the custom array.

CONCLUSION

Peripheral blood gene expression profiling (GEP) in SLE allows patients to be categorised into two groups based on a high or low IFN gene signature. Disease activity measured using the SLEDAI-2K is correlated with the high IFN gene signature, indicating that GEP may be a useful biomarker of disease activity in SLE.

摘要

目的

确定系统性红斑狼疮(SLE)患者的外周血基因表达是否与使用2000年SLE疾病活动指数(SLEDAI - 2K)测量的疾病活动相关。

方法

从269例SLE患者的外周血中分离RNA,并在定制微阵列上进行分析。使用层次聚类和热图根据基因表达模式将样本分类为主要簇。使用多变量回归模型比较主要样本簇的相关因素,包括人口统计学和疾病相关特征,如SLEDAI - 2K评分。

结果

一组31个干扰素(IFN)调节基因被发现驱动样本分为两个簇,一个簇的特征是IFN调节基因特征相对较高(n = 150),另一个簇的特征是IFN调节基因特征相对较低(n = 119)。使用SLEDAI - 2K测量的疾病活动与高IFN基因特征显著相关。在多变量回归分析中,SLEDAI - 2K的免疫成分以及抗U1RNP抗体的存在是高IFN基因特征的显著相关因素。在定制阵列上分析的156个非IFN调节基因没有可识别的相关因素。

结论

SLE患者的外周血基因表达谱分析(GEP)可根据高或低IFN基因特征将患者分为两组。使用SLEDAI - 2K测量的疾病活动与高IFN基因特征相关,表明GEP可能是SLE疾病活动的有用生物标志物。

相似文献

1
Association of a gene expression profile from whole blood with disease activity in systemic lupus erythaematosus.全血基因表达谱与系统性红斑狼疮疾病活动度的关联
Ann Rheum Dis. 2008 Aug;67(8):1069-75. doi: 10.1136/ard.2007.074765. Epub 2007 Dec 6.
2
Higher interferon score and normal complement levels may identify a distinct clinical subset in children with systemic lupus erythematosus.较高的干扰素评分和正常的补体水平可能在儿童系统性红斑狼疮中识别出一个独特的临床亚组。
Arthritis Res Ther. 2020 Apr 25;22(1):91. doi: 10.1186/s13075-020-02161-8.
3
A cluster of type II interferon-regulated genes associates with disease activity in patients with systemic lupus erythematosus.一组 II 型干扰素调节基因与系统性红斑狼疮患者的疾病活动相关。
J Autoimmun. 2022 Oct;132:102869. doi: 10.1016/j.jaut.2022.102869. Epub 2022 Aug 4.
4
Comparison of Surrogate Markers of the Type I Interferon Response and Their Ability to Mirror Disease Activity in Systemic Lupus Erythematosus.比较 I 型干扰素反应的替代标志物及其在系统性红斑狼疮中反映疾病活动的能力。
Front Immunol. 2021 Jun 30;12:688753. doi: 10.3389/fimmu.2021.688753. eCollection 2021.
5
Interferon score is increased in incomplete systemic lupus erythematosus and correlates with myxovirus-resistance protein A in blood and skin.干扰素评分在不完全性系统性红斑狼疮中增加,并与血液和皮肤中的抗粘液病毒蛋白 A 相关。
Arthritis Res Ther. 2019 Dec 2;21(1):260. doi: 10.1186/s13075-019-2034-4.
6
Interferon signature gene expression is correlated with autoantibody profiles in patients with incomplete lupus syndromes.干扰素特征基因表达与不完全狼疮综合征患者的自身抗体谱相关。
Clin Exp Immunol. 2010 Mar;159(3):281-91. doi: 10.1111/j.1365-2249.2009.04057.x. Epub 2009 Dec 1.
7
Lack of association between the interferon-alpha signature and longitudinal changes in disease activity in systemic lupus erythematosus.系统性红斑狼疮中干扰素α特征与疾病活动度纵向变化之间缺乏相关性。
Ann Rheum Dis. 2009 Sep;68(9):1440-6. doi: 10.1136/ard.2008.093146. Epub 2008 Sep 4.
8
Systemic sclerosis and lupus: points in an interferon-mediated continuum.系统性硬化症与狼疮:干扰素介导连续体中的要点
Arthritis Rheum. 2010 Feb;62(2):589-98. doi: 10.1002/art.27224.
9
Interferon and granulopoiesis signatures in systemic lupus erythematosus blood.系统性红斑狼疮血液中的干扰素和粒细胞生成特征
J Exp Med. 2003 Mar 17;197(6):711-23. doi: 10.1084/jem.20021553.
10
Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.系统性红斑狼疮患者中干扰素诱导基因表达增加与疾病活动及狼疮性肾炎的关联。
Arthritis Rheum. 2006 Sep;54(9):2951-62. doi: 10.1002/art.22044.

引用本文的文献

1
Immunotargets and Therapy for Systemic Lupus Erythematosus.系统性红斑狼疮的免疫靶点与治疗
Immunotargets Ther. 2025 Jun 24;14:605-629. doi: 10.2147/ITT.S485650. eCollection 2025.
2
Coordinated, multicellular patterns of transcriptional variation that stratify patient cohorts are revealed by tensor decomposition.张量分解揭示了对患者队列进行分层的转录变异的协调多细胞模式。
Nat Biotechnol. 2024 Sep 23. doi: 10.1038/s41587-024-02411-z.
3
Identification of NET formation and the renoprotective effect of degraded NETs in lupus nephritis.
鉴定 NET 形成和降解 NETs 在狼疮肾炎中的肾保护作用。
Am J Physiol Renal Physiol. 2024 Oct 1;327(4):F637-F654. doi: 10.1152/ajprenal.00122.2024. Epub 2024 Aug 29.
4
Advances in natural products and antibody drugs for SLE: new therapeutic ideas.系统性红斑狼疮天然产物和抗体药物的进展:新的治疗思路
Front Pharmacol. 2023 Jul 10;14:1235440. doi: 10.3389/fphar.2023.1235440. eCollection 2023.
5
Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider.自身免疫和肌肉骨骼疾病中 I 型干扰素通路激活与临床结局的相关性:一项系统文献回顾,为 EULAR 要点提供信息。
RMD Open. 2023 Mar;9(1). doi: 10.1136/rmdopen-2022-002864.
6
Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider.I 型干扰素通路检测在风湿和肌肉骨骼疾病研究中的应用:系统文献综述为 EULAR 考虑要点提供信息。
RMD Open. 2023 Mar;9(1). doi: 10.1136/rmdopen-2022-002876.
7
Regulation of cGAS-STING Pathway - Implications for Systemic Lupus Erythematosus.cGAS-STING通路的调控——对系统性红斑狼疮的影响
Rheumatol Immunol Res. 2021 Dec 15;2(3):173-184. doi: 10.2478/rir-2021-0023. eCollection 2021 Sep.
8
Harnessing Tolerogenic Histone Peptide Epitopes From Nucleosomes for Selective Down-Regulation of Pathogenic Autoimmune Response in Lupus (Past, Present, and Future).利用核小体中的耐受组蛋白肽表位选择性下调狼疮中的致病性自身免疫反应(过去、现在和未来)。
Front Immunol. 2021 Apr 14;12:629807. doi: 10.3389/fimmu.2021.629807. eCollection 2021.
9
The baseline interferon signature predicts disease severity over the subsequent 5 years in systemic lupus erythematosus.基线干扰素特征可预测系统性红斑狼疮患者未来5年的疾病严重程度。
Arthritis Res Ther. 2021 Jan 16;23(1):29. doi: 10.1186/s13075-021-02414-0.
10
Interferon score is increased in incomplete systemic lupus erythematosus and correlates with myxovirus-resistance protein A in blood and skin.干扰素评分在不完全性系统性红斑狼疮中增加,并与血液和皮肤中的抗粘液病毒蛋白 A 相关。
Arthritis Res Ther. 2019 Dec 2;21(1):260. doi: 10.1186/s13075-019-2034-4.